SCHEMBL29567157

SCHEMBL29567157

Cn1cc(S(=O)(=O)Nc2nc(Cl)cc(Oc3ccc(N4CCNCC4)cc3)n2)cn1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 4/20 0.41
▸ HTR6 P50406 4/20 0.40
▸ GUSB P08236 3/20 0.40
▸ NMT1 P30419 1/20 0.39
▸ PLA2G7 Q13093 1/20 0.38
▸ RIPK2 O43353 2/20 0.38
▸ ACVR1 Q04771 2/20 0.38
▸ NOD2 Q9HC29 2/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ HTR3E A5X5Y0 1/20 0.36
▸ HTR3B O95264 1/20 0.36
▸ ADRB1 P08588 1/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ HTR3D Q70Z44 1/20 0.36
▸ HTR3C Q8WXA8 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ EGFR P00533 2/20 0.36
▸ MAPK8 P45983 1/20 0.35
▸ MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309513 1.00 LTA4H (0.41) LTA4HHTR6GUSBNMT1PLA2G7
SCHEMBL26807760 0.94 LTA4H (0.48) LTA4HHTR6GUSBNMT1PLA2G7
SCHEMBL26807778 0.91 HTR3E (0.46) HTR6GUSBRIPK2ACVR1NOD2
SCHEMBL26807780 0.91 LTA4H (0.47) LTA4HHTR6GUSBRIPK2ACVR1
SCHEMBL29566336 0.91 DGAT2 (0.42) HTR6EGFR
SCHEMBL24309631 0.91 DGAT2 (0.42) HTR6EGFR
SCHEMBL26807769 0.90 GUSB (0.43) LTA4HHTR6GUSBHTR3EHTR3B
SCHEMBL26807751 0.89 GUSB (0.41) LTA4HHTR6GUSBNMT1PLA2G7
SCHEMBL26807480 0.89 LTA4H (0.43) LTA4HHTR6GUSBNMT1RIPK2
SCHEMBL26807468 0.87 GUSB (0.42) LTA4HHTR6GUSBNMT1PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback